Collection of clinical specimens for pediatric liver disease research

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to create a biobank that systematically collects clinical specimens from children diagnosed with end-stage liver disease who are undergoing liver transplantation. The collected specimens will be used to support future research and development related to pediatric liver diseases. The study is observational and does not involve any interventions, focusing instead on gathering valuable data for long-term analysis. The goal is to enhance understanding and treatment options for pediatric liver conditions.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Children diagnosed with end-stage liver disease.
2. Liver transplantation in our hospital.
3. informed patient consent.
4. long-term follow-up in our hospital.

Exclusion Criteria:

No fixed contact information, difficult to follow up the patients.

Where it's running

• Children's Hospital of Chongqing Medical University
  Chongqing, Chongqing Municipality, China Recruiting

Study contacts

• Study coordinator: Xiang Zheng
• Email: xiangzheng061@163.com
• Phone: 17723191712

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Liver transplantation outcomes for patients with severe liver failure

  This study is testing how well liver transplants work for people with severe liver failure compared to those with advanced cirrhosis to see which group has better survival rates and quality of life after the transplant.

  Recruiting at 69 sites European Foundation for Study of Chronic Liver Failure · Los Angeles, California and 105 other locations · NCT04613921

• Nature-based program feasibility in preschools near public housing

  This feasibility study tests whether a nature-based program in preschools near public housing can be run smoothly and whether families will participate and benefit.

  Recruiting University Hospital Bispebjerg and Frederiksberg · Frederiksberg · NCT07780123

• Expanding HIV-positive donor livers for HIV-positive recipients

  This study tests whether liver transplants from HIV-positive donors to HIV-positive recipients are safe regarding opportunistic infections and cancer.

  Recruiting at 2 sites National Institute of Allergy and Infectious Diseases (NIAID) · Baltimore, Maryland and 1 other locations · NCT07778459

• Everolimus-based calcineurin-free immunosuppression one year after liver transplant

  This trial tests whether switching to or using everolimus with reduced calcineurin inhibitors after year one post-liver transplant can protect kidney function while maintaining graft health in adults at low rejection risk.

  Recruiting Phase 3 Hannover Medical School · Heidelberg, Baden-Wurttemberg and 15 other locations · NCT07739914

• Magnetic Resonance Cholangiopancreatography to help living liver donors and their recipients

  This study tests whether preoperative MRCP imaging can help select living liver donors and reduce biliary complications in recipients.

  Recruiting Institute of Liver and Biliary Sciences, India · New Delhi · NCT07715500

• Metastatic liver cancer patient registry from multiple Chinese centers

  This is a registry that collects real-world data on adults with liver metastases to understand patterns and prognosis and to support future research.

  Recruiting at 2 sites Anhui Provincial Hospital · Bengbu, Anhui and 2 other locations · NCT07602504

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.